Lycera Corp

Lycera Corp is a biopharmaceutical company based in Plymouth Meeting, PA, specializing in the development of novel small molecule drugs for the treatment of autoimmune diseases. The company focuses on advancing innovative therapies that target immune system pathways to address unmet medical needs.

With a commitment to scientific excellence, Lycera Corp conducts research and clinical trials to bring potential breakthrough treatments to patients. By leveraging cutting-edge technology and expertise in immunology, the company aims to make a meaningful impact in the field of autoimmune disease therapeutics.

Generated from their business information